Sector News

Google launches virtual medical research app, starting with studies in the flu and COVID-19

December 13, 2020
Life sciences

Google has launched its own virtual clinical research app for Android phones—and it’s starting with studies into respiratory diseases such as COVID-19.

According to the tech giant, the app allows any user to sign up and volunteer to participate in medical research, after submitting data about themselves and answering a questionnaire.

The goal is to furnish a platform for scientists, who can poll the system to find the people they need to help answer their research questions. And by lowering barriers to entry, Google ultimately hopes to provide a large and diverse population of potential study participants.

In this manner, the app is similar in structure to one launched by Apple for its iPhones, iPads and smartwatches last year, which has included studies in cardiovascular health, hearing and women’s health and fertility—with one heart-focused study canvassing more than 400,000 people in less than nine months.

Google’s first project will be launched in partnership with Harvard Medical School and Boston Children’s Hospital focused on respiratory infections like influenza and the novel coronavirus.

By tracking adults across the U.S., the researchers hope to see how these diseases evolve and spread through communities, while gauging how age and different activities—such as how many daily trips a person takes outside the home—contribute to potential risk factors.

“With COVID-19 emerging alongside seasonal respiratory pathogens, research is now needed more than ever to develop more effective treatments and mitigation strategies,” said John Brownstein, Ph.D., a professor at Harvard Medical School and chief innovation officer at Boston Children’s.

Volunteers will use Google’s app to report symptoms, any preventive measures they’ve taken and medical information such as test results. Participants’ data will be encrypted, and they will have control over what is contributed and shared; no data will be sold or shared with advertisers, Google said. In addition, the app will help users access any research findings once they are published.

by Conor Hale

Source: fiercebiotech.com

comments closed

Related News

May 21, 2022

As monkeypox cases emerge in US and Europe, Bavarian Nordic inks vaccine order

Life sciences

A monkeypox outbreak is emerging in the U.S. and Europe, and at least one country is amping up countermeasure preparedness. Bavarian Nordic has secured a contract with an unnamed European country to supply its smallpox vaccine, called Imvanex in Europe, in response to the emergence of monkeypox cases, the Danish company said Thursday.

May 21, 2022

Moderna chairman Afeyan defends hiring practices after CFO debacle: report

Life sciences

Moderna’s recent chief financial officer debacle—in which Jorge Gomez departed on his second day on the job—raised questions about the company’s hiring process given its rush to global biopharma prominence. The most obvious one: How was it possible for Gomez to be hired when he was under investigation by his previous employer, Dentsply Sirona of Charlotte, N.C.

May 21, 2022

Merck to pay up to $1.4B in cancer deal with Kelun, but details are scarce

Life sciences

Merck & Co. is plucking a cancer project from the branch of Chinese-based Kelun Pharmaceutical for up to $1.4 billion, but details from the New Jersey-based Big Pharma have been hard to come by. The deal, first disclosed Monday on the Shenzhen stock exchange, has Merck handing over $47 million in upfront cash in exchange for ex-China rights to a “macromolecular tumor project.”